ArticleMethods in molecular biology (Clifton, N.J.)2026
Protocol for Cryopreservation of Endothelial Monolayers: An Update.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the cryobiological responses of endothelial cells is important to ensure the successful cryopreservation of vascularized tissues and organs. The endothelium, a monolayer of endothelial cells comprising the inner lining of blood vessels and other tissues such as the cornea, is sensitive to cryoinjury. In this chapter, we update our published cryopreservation protocol, which we have since validated for several more cell types. Our optimized protocol involves culturing cells on Rinzl plastic coverslips, using a combination of a permeating cryoprotectant (5% dimethyl sulfoxide) and a non-permeating cryoprotectant (6% hydroxyethyl starch), addition of 2% chondroitin sulfate, controlled-rate slow cooling, storage in liquid nitrogen, and removal of cryoprotectants immediately after thaw. Our post-thaw assessments include membrane integrity and a functional assay immediately after thaw and after extended incubation in culture conditions.
Indexed as
Identifiers
42732518What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.